News
Ozempic's double-sided coin: Amid skyrocketing popularity of GLP-1 drugs, a burgeoning lawsuit looms
Ozempic was originally approved by the Food and Drug Administration (FDA) to treat people with Type 2 diabetes, who risk ...
The lawsuit accuses drug manufacturer Novo Nordisk of failing to warn patients of the possible association between the ...
The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...
A man is suing the manufacturers of Ozempic, alleging the diabetes drug caused him to go blind. The medication, containing ...
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
A Maryland man has filed a lawsuit against the manufacturers of Ozempic, alleging that his use of the drug led to him ...
We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Hosted on MSN18d
Say goodbye to cheap versions of Ozempic and WegovyOther developments include news that GLP-1 pills ... Generic versions of Ozempic, Wegovy, and Mounjaro flooded into the market via med spas and online pharmacies. In February of this year, the ...
Ozempic and other drugs like it have been threatening the established diet industry since they premiered — and it appears that Weight Watchers is now getting the hatchet. In a note to investors ...
GLP-1 drugs like Ozempic and Wegovy have been linked to ... But the researchers found that the impact these drugs have on cancer development is greater than just aiding weight loss.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results